Schedule 13D ownership disclosure
APTEVO THERAPEUTICS INC
Security class unavailable · CUSIP: 03835L207
Event date: 2021-06-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,760,000
- Percent of class
- 39.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-21-006726
- Form type
- SC 13D
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Jun 21, 2021
- Reporting period
- Jun 21, 2021
- Description
- Schedule 13D beneficial ownership